Latest effect observation of laparoscopic sleeve gastrectom y in treating obesity combined with type 2 diabetesmellitus
LIXiao-long1 ZHAO Hao-liang2▲ HAN Jian-li2
1.Shanxi Medical University,Taiyuan 030001,China;
2.Department of General Surgery,Affiliated Dayi Hospital of ShanxiMedical University in Shanxi Province,Taiyuan 030031,China
Abstract：ObjectiveTo explore the latest effect of laparoscopic sleeve gastrectomy(LSG)in treating obesity combined with type 2 diabetesmellitus.Methods12 obesity patients combined with type 2 diabetesmellitus conducted LSG in Affiliated Dayi Hospital of Shanxi Medical University from April 2013 to May 2015 were selected.Followed-up for 6 months after operation,the changes of related index like weight,body mass index (BMI),excess weight loss rate (EWL%),fasting plasma glucose (FPG),fasting insulin (FINS)and homeostatic model assessment of insulin resistance (HOMA-IR)of patients before and after operation were compared.Results12 cases operated successfully,no conversion to open surgery during operation and no serious complicationswere found after operation.Postoperative followed-up for 1,3 and 6months,weight,BMI,FPG,FINSand HOMA-IR of patients at each time after operation was lower than that before operation(P＜0.05);EWL%was in upward trend(P＜0.05).ConclusionLSG in treating obesity combined with type 2 diabetesmellitus has effective latesteffects.
Wang Y，Liu J.Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy[J].Obes Surg，2009，19（3）：357-362.
[8]
Abbatini F，Capoccia D，Casella G，et al.Type 2 diabetes in obese patientswith bodymass index of 30-35 kg/m2：sleeve gastrectomy versus medical treatment[J].Surg Obes Relat Dis，2012，8（1）：20-24.
[9]
Kakoulidis TP，Karringer A，Gloaguen T，et al.Initial results with sleeve gastrectomy for patient swith class I obesity （BMI 30-35 kg/m2）[J].Surg Obes Relat Dis，2009，5（4）：425-428.
京公网安备 11010502046607号